PharmiWeb.com - Global Pharma News & Resources
21-Jun-2023

Brain Implants Market is anticipated to reach US$ 18 billion by 2032, at a CAGR of 12.3%

The global Brain Implants market demand is predicted to grow at a 12.3% CAGR to US$ 18 billion by 2032.

According to GLOBOCAN 2020 statistics, there were approximately 308,102 cases of brain and nervous system cancer recorded globally in 2020. Trauma, malignant tumours, external decompression of intracranial pressure, and congenital malformations are all manifestations of cranial anomalies. The rise in such illnesses has created new chances for brain implant market participants, which might be beneficial to the technology’s ongoing development and adoption.

Request a Sample Report with Table of Content@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15093

What Could be the most Serious Issue with Brain Implantation In The Future?

Americans are significantly more inclined to express misgivings about implanting computer chips in human brains than enthusiasm. Manufacturers of brain implant chips are also working hard to create more technologically advanced options. And about twice as many of them do not believe they would be willing to employ this technology as do.

Furthermore, individuals in the United States are more inclined to consider this form of technology to be morally undesirable, with many remaining unsure about the moral consequences. Religious institutions’ attitudes on this technology vary greatly. Americans who are deeply religious, including those who believe in gene editing, are more inclined to regard such technology as “meddling with nature.”

Region-Wise Insights

Which Region is projected to Offer the Largest Brain Implants Market Opportunity?

During the forecast period, the North American Brain Implants Market is expected to be the major market for Brain Implants. According to Alzheimer’s Disease Facts and Figures, as the number of older persons in the United States grows, so will the number of new and ongoing instances of Alzheimer’s.

Without medical advances to prevent, halt, or cure Alzheimer’s disease, the number of individuals aged 65 and older living with the condition is predicted to climb to 12.7 million by 2050.

Ask More About This Market’s Geographical Distribution Along With a Detailed Analysis of the Top Regions@ https://www.futuremarketinsights.com/ask-question/rep-gb-15093

Recent Developments:

  • In April 2022, the FDA approved brain stimulation software for use in Parkinson’s disease. Vercise Neural Navigator with Stimview XT will allow clinicians to visualize the lead placement and stimulation modelling, and is designed to provide patient-specific 3D modeling for therapeutic customization. The software is intended to aid in the placement of leads, minimise programming time, and allow for more informed treatment.
  • In June 2021, Medtronic plc received FDA approval for its SenSight Directional Lead System, which is used for deep brain stimulation therapy.
  • In March 2021, Abbott announced the launch of NeuroSphere Virtual Clinic. Deep brain stimulation patients can get programmed their devices and reset them remotely, from the comfort of their own homes, without travelling to a specialist, owing to a newly launched FDA-approved tool.

Key Companies Profiled

  • Abbott Laboratories
  • Medtronic PLC
  • NeuroPace Incorporation
  • Nevro Corporation
  • Aleva Neurotherapeutics SA
  • Synapse Biomedical Incorporation
  • Boston Scientific Corporation
  • Sapiens Neuro
  • Edwards Lifesciences Corporation

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/15093

Brain Implants Market Segmentation

By Product Type:

  • Deep Brain Stimulator
  • Spinal Cord Stimulator
  • Vagus Nerve Stimulator

By Application:

  • Brain Implant for Chronic Pain
  • Brain Implant for Epilepsy
  • Deep Brain Simulation for Parkinson’s Disease
  • Brain Implant for Depression
  • Brain Implant for Essential tremor
  • Brain Implant for Alzheimer’s Disease

About Future Market Insights, Inc.

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs

Editor Details

Last Updated: 21-Jun-2023